Litcius/Paper detail

Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain

Michael Brand, James Clayton, Mustafa Moroglu, Matthias Schiedel, S. Picaud, Joseph P. Bluck, Anna Skwarska, Hannah R. Bolland, Anthony Chan, Corentine M. C. Laurin, Amy R. Scorah, Larissa See, Timothy P. C. Rooney, Katrina H. Andrews, Oleg Fedorov, Gabriella Perell, Prakriti Kalra, Kayla B. Vinh, Wilian A. Cortopassi, Pascal Heitel, Kirsten E. Christensen, Richard I. Cooper, Robert S. Paton, William C. K. Pomerantz, Philip C. Biggin, Ester M. Hammond, P. Filippakopoulos, Stuart J. Conway

2021Journal of Medicinal Chemistry26 citationsDOIOpen Access PDF

Abstract

), the inhibition of the CREBBP/EP300 bromodomain results in the enhanced stabilization of HIF-1α.

Topics & Concepts

BromodomainCREB-binding proteinChemistryAcetylationBRD4BiochemistryHistoneCell biologyTranscription factorBiologyGeneCREBProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysPeptidase Inhibition and Analysis
Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain | Litcius